“This is quite exciting,” said Dr. Shirish M. Gadgeel, a medical oncologist at the Henry Ford Cancer Institute in Detroit.

The global health organization says the lack of rapid diagnostic tests results in undertreatment and overtreatment of ...

Updated guidelines recommend fidaxomicin as the first-line agent for C difficile infection, but researchers found use in US ...

On Friday, Merck & Co Inc (MRK) stock saw a modest uptick, ending the day at $113.69 which represents a slight increase of $0.60 or 0.53% from the prior close of $113.09. The stock opened at $113.17 ...

We recently published a list of 10 Best Major Stocks to Invest In According to Analysts. In this article, we are going to ...

After hours of company pushback, FDA's Oncologic Drugs Advisory Committee voted that the benefit of immunotherapy in low or ...

Roche said it plans to focus on five key therapeutic areas as part of its new pharma strategy through 2030. The company will prioritize work in the areas of neurology, oncology and hematology, ...

This week on Pipeline Moves, the Clinical Trials Arena team investigates candidates in oncology, central nervous system and ...

Merck Foundation, the philanthropic arm of Merck KGaA Germany marks 'World Heart Day 2024' in partnership with Africa's First Ladies, Ministries of Health, Medical Societies, and Academia, through ...